A Clinical Study to Explore CT1195E in Patients With Relapsed/Refractory B-Cell Neoplasms

NCT07234045 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Relapsed/Refractory B-cell ALL

Interventions

DRUG: CAR T cells chimeric antigenreceptor cells

Sponsor

Institute of Hematology & Blood Diseases Hospital, China